Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Randomized Trial of Clinical Efficiency and Safety of Cell Product of Autologous Bone Marrow-derived Mesenchymal Stem Cells for Reparative Treatment of Destructively Changed Endometrium in Patients With Repeated IVF Failures

NCT03166189 is registered in ClinicalTrials.gov with D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology as lead sponsor.

NCT NCT03166189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03166189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Randomized Trial of Clinical Efficiency and Safety of Cell Product of Autologous Bone Marrow-derived Mesenchymal Stem Cells for Reparative Treatment of Destructively Changed Endometrium in Patients With Repeated IVF Failures
Lead sponsor
D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology
Phase
Phase 2
Overall status
Completed
Start date
December 20, 2017
Completion date
December 28, 2019
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asherman syndrome, infertility of uterine origin, infertility, female